Patents matching “The United States of America as represented by the Secretary of the Department of”

US 8852605

Vibrio cholerae O139 conjugate vaccines

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Oct 7, 2014 · Expires Oct 2, 2034

US 8846051

Modulation of replicative fitness by deoptimization of synonymous codons

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Sep 30, 2014 · Expires Sep 25, 2034

US 8846056

Anti-RSV immunogens and methods of immunization

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control · Granted Sep 30, 2014 · Expires Sep 25, 2034

US 8841266

Pharmaceutical composition and method for regulating abnormal cellular proliferation

The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Sep 23, 2014 · Expires Sep 18, 2034

US 8835378

Multi-domain amphipathic helical peptides and methods of their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

US 8835167

Humanized anti-tag 72 CC49 for diagnosis and therapy of human tumors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 16, 2014 · Expires Sep 11, 2034

US 8828717

Framework residue substituted humanized COL-1 antibodies and their use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

US 8828356

Farnesyltransferase inhibitors for treatment of laminopathies, cellular aging and atherosclerosis

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 9, 2014 · Expires Sep 4, 2034

US 8822192

Human rotavirus vaccine strains and diagnostics

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Sep 2, 2014 · Expires Aug 28, 2034

US 8809502

Mutated anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 19, 2014 · Expires Aug 14, 2034

US 8778671

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine to prevent disease caused by West Nile virus

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 15, 2014 · Expires Jul 10, 2034

US 8778847

Immunogenic peptides of influenza virus

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 15, 2014 · Expires Jul 10, 2034

US 8772238

Use of ixolaris, a tissue factor inhibitor, for the treatment of cancer

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 8, 2014 · Expires Jul 3, 2034

US 8771706

Anti-RSV immunogens and methods of immunization

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jul 8, 2014 · Expires Jul 3, 2034

US 8747863

Vaccine for shigella

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

US 8748114

ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic lymphoma (CLL/SLL)

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

US 8748608

4-phenylpiperazine derivatives with functionalized linkers as dopamine D3 receptor selective ligands and methods of use

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 10, 2014 · Expires Jun 5, 2034

US 8741947

Biologically active macrolides, compositions, and uses thereof

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

US 8741869

Oligodeoxynucleotide and its use to induce an immune response

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Jun 3, 2014 · Expires May 29, 2034

US 8735355

Methods of use of fragments of secreted frizzled related protein, sFRP

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

US 8735407

Purine derivatives as A3 adenosine receptor-selective agonists

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 27, 2014 · Expires May 22, 2034

US 8729053

Nuclear factor kappa B pathway inhibitor composition and use of same

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 20, 2014 · Expires May 15, 2034

US 8715689

Chimeric west nile/dengue viruses

The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted May 6, 2014 · Expires May 1, 2034

US 8716315

Analogs of thalidomide as potential angiogenesis inhibitors

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted May 6, 2014 · Expires May 1, 2034